Showing 3591-3600 of 5910 results for "".
- Earlier Detection of Diabetic Retinopathy with Smartphone AIhttps://modernod.com/news/earlier-detection-of-diabetic-retinopathy-with-smartphone-ai/2476559/A novel pairing of two technologies may offer a solution for better screening for diabetic ret
- Thomas Walters, MD, Presents Update on Nicox’s NCX 470 Phase 2 Clinical Study in Podium Presentation at ASCRS 2019https://modernod.com/news/thomas-walters-md-presents-update-on-nicoxs-ncx-470-phase-2-clinical-study-in-podium-presentation-at-ascrs-2019/2476555/Nicox SA announced that ophthalmology key opinion leader and clinical investigator in the ongoing NCX 470 phase 2 clinical study, Thomas Walters, MD, delivered a podium presentation at the annual ASCRS 2019 meeting in San Diego updating on the progress of the NCX 470 phase 2 clinical study in pat
- Johnson & Johnson Vision Showcases the Rising Burden of Myopia, New Contact Lens and Surgical Technologies at ARVOhttps://modernod.com/news/johnson-johnson-vision-showcases-the-rising-burden-of-myopia-new-contact-lens-and-surgical-technologies-at-arvo/2476549/Johnson & Johnson Vision showcased new research abstracts covering topics across a range of eye health needs at the Association for Research in Vision and Ophthalmology annual meeting (ARVO) in Vancouver, Canada, April 28-May 2, 2019. Presentations included the first predictive model for dire
- Verseon Presents Oral Drug Candidate for Diabetic Eye Diseasehttps://modernod.com/news/verseon-presents-oral-drug-candidate-for-diabetic-eye-disease/2476516/Verseon presented promising preclinical efficacy data for the first development candidate for clinical trials in their diabetic eye disease program at this week’s ARVO 2019 annual meeting in Vancouver. This new drug candidate for oral dosing could lead to the first real alternative to eye injecti
- Novaliq and BLP Management Group Establish New Company, Betaliq, to Leverage EyeSol Technology to Treat Glaucomahttps://modernod.com/news/novaliq-and-blp-management-group-establish-new-company-betaliq-to-leverage-eyesol-technology-to-treat-glaucoma/2476500/Novaliq and BLP Management group announced the formation and funding of Betaliq. The Tampa-based company’s pipeline consists of two preservative-free glaucoma drug candidates based on new in class and best in class ß-blocker molecules using Novaliq’s waterfree EyeSol technology. Two EyeSol-
- James Mazzo Joins Board of Directors at Avellino Labshttps://modernod.com/news/james-mazzo-joins-board-of-directors-at-avellino-labs/2476451/Avellino Labs announced the strategic addition of James V. Mazzo to its board of directors. The partnership will further anchor Avellino Lab’s leadership in developing the science and setting the standard of genetic testing in ophthalmology, according to a company news release.
- Improved Premium IOLs Will Drive Growth in the Global IOL Market Over the Next 5 Yearshttps://modernod.com/news/improved-premium-iols-will-drive-growth-in-the-global-iol-market-over-the-next-5-years/2476449/Innovation in premium lens technology will fuel patient demand in the global IOL market over the next 5 years, according to a Market Scope report. The improved technology will provide better visu
- IStent Inject Device Lowers IOP After Cataract Surgery in Glaucoma Patientshttps://modernod.com/news/istent-inject-device-lowers-iop-after-cataract-surgery-in-glaucoma-patients/2476438/In patients with mild to moderate glaucoma and cataract, the second-generation iStent inject system, with two redesigned stents, reduces IOP more than cataract surgery alone, according to results of a new pivotal trial, as reported by Reut
- Lightmed and Mexico’s Leading Pediatric Hospitals Partner in Childhood Blindness Preventionhttps://modernod.com/news/lightmed-and-mexicos-leading-pediatric-hospitals-partner-in-childhood-blindness-prevention/2476428/Lightmed Corp. announced the successful installation and support of 34 LIGHTLas 810 photocoagulator lasers across 32 Mexican states. Mexico’s Ministry of Health initially purchased 18 Lightmed lasers to be placed in areas with the most urgent need. Soon after, they ordered an additional 16 units
- Higher Calcium Intake Tied to Slower AMD Progressionhttps://modernod.com/news/higher-calcium-intake-tied-to-slower-amd-progression/2479580/Higher levels of dietary and supplementary calcium intake are associated with a lower risk of progression to late age-related macular degeneration (AMD), according to a secondary analysis of data from a large trial, as reported by Reuters.